Evaluation of the Relationship Between Adenomyosis and Elastographic Properties of the Cervix
1 other identifier
observational
130
1 country
1
Brief Summary
This study aims to evaluate the potential of cervical elastography, a non-invasive method, in the accurate diagnosis and clinical course of adenomyosis. Cervical elastography is an imaging method that measures the elasticity properties of cervical tissue using ultrasound technology. This method may be helpful in providing information about the development and clinical course of adenomyosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 18, 2023
CompletedFirst Submitted
Initial submission to the registry
January 13, 2024
CompletedFirst Posted
Study publicly available on registry
January 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 18, 2024
CompletedJanuary 25, 2024
January 1, 2024
2 months
January 13, 2024
January 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnosis of Adenomyosis
MUSA Criteria
2 months
Secondary Outcomes (1)
Diagnosis of Adenomyosis-Cervical Elastography
4 months
Study Arms (2)
Adenomyosis-Case Group
The study will include those diagnosed with adenomyosis who were evaluated by gynecological examination and ultrasonographic imaging after the application to Etlik City Hospital Gynecology and Obstetrics Clinic, aged 18-45 reproductive period, pregnancy status excluded, without cervical infection, pathology and anomaly, without systemic disease findings and diagnoses, without chronic drug use.
Healthy patients-Control
The study will include those who have been gynecologically examined and evaluated with ultrasonographic imaging after the application to Etlik City Hospital Gynecology and Obstetrics Clinic, aged 18-45 reproductive period, pregnancy status excluded, without cervical infection, pathology and anomaly, without systemic disease findings and diagnoses, without chronic drug use, without adenomyosis diagnosis.
Eligibility Criteria
The study will be included in our study as two case groups with and without the diagnosis of adenomyosis, whose age is 18-45 reproductive period, pregnancy status is excluded, without cervical infection, pathology and anomaly, without systemic disease findings and diagnoses, without chronic drug use, whose gynecological examination was performed and evaluated by ultrasonographic imaging after the application to Etlik City Hospital Gynecology and Obstetrics Clinic. MUSA criteria will be used in the diagnosis of adenomyosis and elastography measurements in kPa will be performed similar to the studies in the literature examples section in the file.
You may qualify if:
- Female patients between 18-45 years of age who volunteered and consented to the reproductive period study
- Patients diagnosed with adenomyosis using MUSA criteria
You may not qualify if:
- Pregnancy status
- Pelvic/Cervical infection, pathology and anomalies
- History of cervical surgery
- Diagnosis and findings of systemic disease
- Chronic drug use
- Advanced maternal obesity preventing measurement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Etlik City Hospital
Ankara, Yenimahalle, 06000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist Doctor
Study Record Dates
First Submitted
January 13, 2024
First Posted
January 25, 2024
Study Start
October 18, 2023
Primary Completion
December 18, 2023
Study Completion
April 18, 2024
Last Updated
January 25, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share
Patient data is not open to access due to hospital policy. however, the principal investigator can be reached via e-mail if necessary